Cargando…
The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance
In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters’ patent expirations, this paper examines the moderating role of firms’ absorptive capacity in external innovation activities of Big Pharma firms. The study indicates a rising interest of Big Pharma in acquisit...
Autores principales: | Fernald, K. D. S., Pennings, H. P. G., van den Bosch, J. F., Commandeur, H. R., Claassen, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322930/ https://www.ncbi.nlm.nih.gov/pubmed/28231332 http://dx.doi.org/10.1371/journal.pone.0172488 |
Ejemplares similares
-
Food-Pharma Convergence in Medical Nutrition– Best of Both Worlds?
por: Weenen, Tamar C., et al.
Publicado: (2013) -
Collaborative Innovation and Absorptive Capacity as an Antecedent on IT Firm Financial Performance
por: Mata, Mário Nuno, et al.
Publicado: (2023) -
Big Pharma (The Play)
por: Bero, Lisa
Publicado: (2007) -
Big Pharma, Big Bucks, and a Big Pile o' Pigs
Publicado: (2001) -
BigPharma and unethical marketing of medicinal products
por: Myhr, Kirsten
Publicado: (2011)